Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

18.16
BATS BZX Real-Time Price
As of 10:54am ET
 -0.26 / -1.41%
Today’s Change
11.41
Today|||52-Week Range
24.88
+48.00%
Year-to-Date

Today’s Trading

Previous close18.42
Today’s open18.33
Day’s range18.00 - 18.33
Volume28,652
Average volume (3 months)1,362,614
Market cap$2.9B
Dividend yield--
Data as of 10:54am ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)-80.33%
Earnings growth (this year)+4.81%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)-28.32%
P/E ratioNM
Price/Sales10.35
Price/Book32.02

Competitors

 Today’s
change
Today’s
% change
JUNOJuno Therapeutics In...-0.21-0.78%
AVXSAveXis Inc-0.07-0.08%
ONCESpark Therapeutics I...-0.77-1.01%
XONIntrexon Corp-0.35-1.99%
Data as of 10:53am ET, 08/18/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)$0.04
Annual revenue (last year)$165.4M
Annual profit (last year)-$153.5M
Net profit margin-92.80%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Operating Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts